GlaxoSmithKline has become the latest drug maker to report their payments to physicians. In addition to publicly reporting what the company pays doctors, Glaxo will also cap payments at $150,000 per year.
GlaxoSmithKline has become the latest drug maker to report their payments to physicians. In addition to publicly reporting what the company pays doctors, Glaxo will also cap payments at $150,000 per year.